FMCG Gurus – Designed to Stand Out: Balancing Distinction and Recognition in a Crowded Market – Trend Report 2026
Report Description:
Food allergies and intolerances are becoming a broader consumer health and food-choice issue, shaped by rising awareness, increased diagnosis, widespread self-diagnosis, and growing concern that food sensitivities can develop over time. The market now extends beyond consumers managing clinically diagnosed conditions to include those experiencing mild or moderate reactions, digestive discomfort, and perceived changes in their ability to tolerate everyday foods. This creates a central challenge for brands: consumers associate food sensitivity with digestive and immune health, yet their understanding of the distinction between allergies and intolerances remains incomplete.
The report explores diagnosis patterns, symptom severity, consumer actions, purchasing habits, claim appeal, trust drivers, pricing expectations, and category opportunities across the global allergies and intolerances market. Its central strategic recommendation is to move beyond allergen avoidance alone while maintaining a clear separation between clinically diagnosed conditions and wider food sensitivity. The report provides practical guidance on developing gut and immune health solutions, targeting distinct consumer needs, prioritizing dairy alternatives and convenient free-from formats, embedding clinical evidence into propositions, and ensuring products remain affordable and easy to integrate into everyday routines.
The Challenge / Problem for Brands:
Brands face a fragmented market in which diagnosed allergies, self-diagnosed intolerances, and broader digestive sensitivities are being treated as overlapping consumer needs despite requiring different products, claims, and levels of evidence. Self-diagnosis is common, most reactions are mild or moderate, and consumers frequently link their symptoms to gut health, lifestyle, food processing, and immune health. A broad or poorly defined proposition therefore creates strategic risk: brands may make claims that do not match consumer needs, confuse genuine medical conditions with wider sensitivities, or rely on wellness messaging without sufficient credibility.
Proposed Solution / Problem It Solves:
Brands should build a two-track strategy that clearly separates products designed for genuine allergies and intolerances from solutions supporting wider food sensitivity, digestive comfort, and gut and immune health. Innovation should address the everyday symptoms consumers actually experience while maintaining precise, evidence-based positioning around what each product can realistically deliver. Successful propositions should combine clinical credibility, healthcare professional validation where appropriate, and convenient everyday formats, creating sustainable value rather than relying solely on specialist free-from positioning or premium wellness claims.
Risk of Getting This Wrong:
Misreading the market could result in products that are poorly targeted, clinically ambiguous, overpriced, or perceived as making exaggerated health claims. Treating all food-sensitive consumers as one audience risks failing both consumers with diagnosed conditions who require clear ingredient avoidance and those seeking support for digestive discomfort. Weak evidence can undermine trust, particularly in a category where healthcare professional endorsement and clinical proof are major credibility drivers, while excessive premiums or price increases can reduce purchase frequency and prevent products from becoming part of regular routines.
This report helps you decide:
- How to separate diagnosed allergies and intolerances from wider food sensitivity when defining target audiences and product propositions.
- How to develop credible gut, digestive, and immune health solutions without overstating allergy or intolerance benefits.
- How to prioritize product formats and categories, including dairy alternatives and convenient free-from foods.
- How to balance clinical evidence, affordability, pricing, and convenience to support regular long-term product use.
Who this is for:
Food and beverage manufacturers, dairy and dairy alternative brands, free-from food producers, functional food and drink companies, nutritional supplement suppliers, retailers, category managers, brand directors, marketing leaders, innovation teams, R&D teams, product managers, consumer insights teams, healthcare and nutrition specialists, ingredient suppliers, commercial strategy leaders, senior decision-makers.
FMCG Gurus – Designed to Stand Out: Balancing Distinction and Recognition in a Crowded Market – Trend Report 2026
Report Description:
Food allergies and intolerances are becoming a broader consumer health and food-choice issue, shaped by rising awareness, increased diagnosis, widespread self-diagnosis, and growing concern that food sensitivities can develop over time. The market now extends beyond consumers managing clinically diagnosed conditions to include those experiencing mild or moderate reactions, digestive discomfort, and perceived changes in their ability to tolerate everyday foods. This creates a central challenge for brands: consumers associate food sensitivity with digestive and immune health, yet their understanding of the distinction between allergies and intolerances remains incomplete.
The report explores diagnosis patterns, symptom severity, consumer actions, purchasing habits, claim appeal, trust drivers, pricing expectations, and category opportunities across the global allergies and intolerances market. Its central strategic recommendation is to move beyond allergen avoidance alone while maintaining a clear separation between clinically diagnosed conditions and wider food sensitivity. The report provides practical guidance on developing gut and immune health solutions, targeting distinct consumer needs, prioritizing dairy alternatives and convenient free-from formats, embedding clinical evidence into propositions, and ensuring products remain affordable and easy to integrate into everyday routines.
The Challenge / Problem for Brands:
Brands face a fragmented market in which diagnosed allergies, self-diagnosed intolerances, and broader digestive sensitivities are being treated as overlapping consumer needs despite requiring different products, claims, and levels of evidence. Self-diagnosis is common, most reactions are mild or moderate, and consumers frequently link their symptoms to gut health, lifestyle, food processing, and immune health. A broad or poorly defined proposition therefore creates strategic risk: brands may make claims that do not match consumer needs, confuse genuine medical conditions with wider sensitivities, or rely on wellness messaging without sufficient credibility.
Proposed Solution / Problem It Solves:
Brands should build a two-track strategy that clearly separates products designed for genuine allergies and intolerances from solutions supporting wider food sensitivity, digestive comfort, and gut and immune health. Innovation should address the everyday symptoms consumers actually experience while maintaining precise, evidence-based positioning around what each product can realistically deliver. Successful propositions should combine clinical credibility, healthcare professional validation where appropriate, and convenient everyday formats, creating sustainable value rather than relying solely on specialist free-from positioning or premium wellness claims.
Risk of Getting This Wrong:
Misreading the market could result in products that are poorly targeted, clinically ambiguous, overpriced, or perceived as making exaggerated health claims. Treating all food-sensitive consumers as one audience risks failing both consumers with diagnosed conditions who require clear ingredient avoidance and those seeking support for digestive discomfort. Weak evidence can undermine trust, particularly in a category where healthcare professional endorsement and clinical proof are major credibility drivers, while excessive premiums or price increases can reduce purchase frequency and prevent products from becoming part of regular routines.
This report helps you decide:
- How to separate diagnosed allergies and intolerances from wider food sensitivity when defining target audiences and product propositions.
- How to develop credible gut, digestive, and immune health solutions without overstating allergy or intolerance benefits.
- How to prioritize product formats and categories, including dairy alternatives and convenient free-from foods.
- How to balance clinical evidence, affordability, pricing, and convenience to support regular long-term product use.
Who this is for:
Food and beverage manufacturers, dairy and dairy alternative brands, free-from food producers, functional food and drink companies, nutritional supplement suppliers, retailers, category managers, brand directors, marketing leaders, innovation teams, R&D teams, product managers, consumer insights teams, healthcare and nutrition specialists, ingredient suppliers, commercial strategy leaders, senior decision-makers.
Files included in this report:
FMCG-Gurus-Allergies-and-Intolerances-Global-Report-2026-.pdf
FMCG-Gurus-Allergies-and-Intolerances-Global-Report-2026.pptx